Tocilizumab i effettive in treating childhood systemic Sclerosis
Too young to fail: a case report on the effectiveness of tocilizumab for paediatric systemic sclerosis-associated interstitial lung disease / Maniscalco V., Marrani E., Rossi E., Maccora I., Mastrolia M.V., Simonini G.. - In: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. - ISSN 0300-9742. - STAMPA. - (2021), pp. 1-2-2. [10.1080/03009742.2021.1881154]
Too young to fail: a case report on the effectiveness of tocilizumab for paediatric systemic sclerosis-associated interstitial lung disease
Maniscalco V.;Marrani E.;Maccora I.;Simonini G.
2021
Abstract
Tocilizumab i effettive in treating childhood systemic Sclerosis
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
